ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: FR-PO1004

Klotho Enhances FoxO3-Mediated Manganese Superoxide Dismutase Expression by Negative Regulation of PI3K/AKT Pathway in Tacrolimus-Induced Oxidative Stress

Session Information

Category: Transplantation

  • 1701 Transplantation: Basic and Experimental

Authors

  • Lim, Sun Woo, The Catholic University of Korea, Seoul, Korea (the Republic of)
  • Shin, Yoo-Jin, The Catholic University of Korea, Seoul, Korea (the Republic of)
  • Luo, Kang, The Catholic University of Korea, Seoul, Korea (the Republic of)
  • Yang, Chul Woo, Seoul St. Mary's Hospital, Seoul, Korea (the Republic of)
Background

Mammalian forkhead members of the class O (FoxO) transcription factor are implicated in the regulation of oxidative stress, and FoxO proteins are negatively regulated by the phosphatidylinositol 3-kinase (PI3K)–AKT signaling pathway. We examined the effect of Klotho on PI3K/AKT pathway and manganese superoxide dismutase (MnSOD) in tacrolimus (Tac)-induced oxidative stress.

Methods

Mice were treated with Tac (1.5 mg/kg, subcutaneously) and recombinant Klotho (rKlotho, shedding form, 10 ug/kg once every 2 days, IP injection) for 4 weeks. For in vitro study, HK-2 cells were seeded in culture plates and treated with Tac (60 ug/mL) and rKlotho (1 ug/mL) with or without LY294003 (25 uM) for 12 h. We examined whether the oxidative stress and signaling pathway are involved in the protection by Klotho using immunoblot, immunostaining, RT-PCR, ChIP assay, oxygen consumption, ect.

Results

Klotho-treated mice showed decreased Tac-induced oxidative stress accompanied by functional and histological improvement. Klotho inhibited the PI3K/AKT-mediated phosphorylation of FoxO3a and enhanced FoxO3a binding to the MnSOD promoter. Klotho increased MnSOD mRNA and protein in mitochondria, and overexpressed MnSOD reduced Tac-induced toxicity in HK-2 cells. In mitochondria, Klotho improved Tac-induced mitochondrial dysfunction and decreased mitochondrial ROS, and this effect was enhanced by blocking PI3K activity with LY294002.

Conclusion

Collectively, Klotho protects Tac-induced oxidative stress by negative regulation of PI3K/AKT pathway, and subsequently enhances FoxO3a-mediated MnSOD expression. Through this mechanism, Klotho may protect against Tac-induced oxidative damage and apoptotic cell death. Finally, our results suggested that Klotho protein or Klotho-enhancing compounds may provide treatment options for nephrotoxicity in the future.

Klotho preserves Tac-induced mitochondrial dysfunction in HK-2 cells.